May 20, 2020 / 04:30PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Good afternoon. Thanks, everybody, for joining us for a fireside chat session here at the UBS Global Virtual Healthcare Conference. I'm Matt Taylor, the U.S. medical supplies and devices analyst for UBS. And I'm really pleased to be joined by management from the Insulet Corporation. Today, we have a few members of the management team, including Wayde McMillan, who's the EVP and Chief Financial Officer and Treasurer of the company. We also got Bret Christensen, EVP and Chief Commercial Officer. And Deb Gordon, VP and Head of the Investor Relations function. So thanks, everybody, for joining us today.
So a couple of points on this session. We're going to have a 40-minute fireside chat. If you have any questions, you want me to ask, just send them to me via e-mail or through the webcast, if I'm not hitting on anything you want to cover.
Insulet Corp at UBS Global Healthcare Conference (Virtual) Transcript
May 20, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers